Angiotensin-Converting Enzyme Inhibitors Concept

subject area of

• A 26-week, prospective, open-label, uncontrolled, multicenter study to evaluate the effect of an escalating-dose regimen of trandolapril on change in blood pressure in treatment-naive and concurrently treated adult hypertensive subjects (TRAIL)  Academic Article
• A multivariate model for predicting mortality in patients with heart failure and systolic dysfunction  Academic Article
• A population‐based study of the drug interaction between clopidogrel and angiotensin converting enzyme inhibitors  Academic Article
• A postmarketing surveillance evaluation of quinapril in 3742 Canadian hypertensive patients: the ACCEPT Study. Accupril Canadian Clinical Evaluation and Patient Teaching.  Academic Article
• A review of heart failure treatment.  Academic Article
• ACE Inhibition in Stable Coronary Artery Disease  Academic Article
• ACE Inhibition in secondary prevention: are the results controversial?  Academic Article
• ACE Inhibitors in Heart Failure  Academic Article
• ACE and Type 2 Diabetes Risk: A Mendelian Randomization Study  Academic Article
• ACE inhibitors for myocardial infarction and unstable angina  Academic Article
• ACE inhibitors: back to prime time?  Academic Article
• ASSOCIATION BETWEEN PSYCHOTROPIC DRUG USE AND HEART FAILURE THERAPY IN ELDERLY LONG-TERM CARE RESIDENTS  Academic Article
• Abnormal renal medullary response to angiotensin II in SHR is corrected by long-term enalapril treatment  Academic Article
• Achieved blood pressure and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials  Academic Article
• Acute Kidney Injury in Patients Receiving Systemic Treatment for Cancer: A Population-Based Cohort Study  Academic Article
• Acute and long-term effects of the angiotensin-converting enzyme inhibitor, enalapril, on adrenergic activity and sensitivity during exercise in patients with left ventricular systolic dysfunction  Academic Article
• Acute change in glomerular filtration rate with inhibition of the renin-angiotensin system does not predict subsequent renal and cardiovascular outcomes  Academic Article
• Adjunctive therapy for myocardial infarction.  Academic Article
• Age and sex differences, and changing trends, in the use of evidence-based therapies in acute coronary syndromes: perspectives from a multinational registry  Academic Article
• Albuminuria and Decline in Cognitive Function<subtitle>The ONTARGET/TRANSCEND Studies</subtitle><alt-title>Albuminuria and Decline in Cognitive Function</alt-title>  Academic Article
• Albuminuria and Rapid Loss of GFR and Risk of New Hip and Pelvic Fractures  Academic Article
• Ambulatory Blood Pressure Values in the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial (ONTARGET)  Academic Article
• An Evaluation of the Safety of Continuing Trastuzumab Despite Overt Left Ventricular Dysfunction  Academic Article
• Analysis of Outcomes in Ischemic vs Nonischemic Cardiomyopathy in Patients With Atrial Fibrillation  Academic Article
• Angiotensin Blockade Does Not Affect Fibrosis Progression in Recurrent Hepatitis C After Liver Transplantation  Academic Article
• Angiotensin Blockade Modulates the Activity of PD1/L1 Inhibitors in Metastatic Urothelial Carcinoma  Academic Article
• Angiotensin Converting Enzyme Inhibitor Dialyzability and Outcomes in Older Patients Receiving Hemodialysis  Academic Article
• Angiotensin receptor blockers in heart failure: meta-analysis of randomized controlled trials  Academic Article
• Angiotensin-Converting–Enzyme Inhibition in Stable Coronary Artery Disease  Academic Article
• Angiotensin-converting enzyme inhibitor as a risk factor for the development of anemia, and the impact of incident anemia on mortality in patients with left ventricular dysfunction  Academic Article
• Angiotensin-converting enzyme inhibitor meta-analysis provides misleading conclusion  Academic Article
• Angiotensin-converting enzyme inhibitor-induced angioedema: Still unrecognized  Academic Article
• Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in atherosclerosis  Academic Article
• Angiotensin-converting enzyme inhibitors as a new therapy for atrial fibrillation? Controversy  Academic Article
• Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers are beneficial in normotensive atherosclerotic patients: a collaborative meta-analysis of randomized trials  Academic Article
• Angiotensin-converting-enzyme inhibitors in early pregnancy  Academic Article
• Angiotensin-converting-enzyme inhibitors in stable vascular disease without left ventricular systolic dysfunction or heart failure: a combined analysis of three trials  Academic Article
• Angiotensin-receptor blockers in prevention of cardiovascular events: are they as effective as angiotensin-converting enzyme inhibitors?  Academic Article
• Anti-ischaemic effects of ACE inhibitors: review of current clinical evidence and ongoing clinical trials.  Academic Article
• Antiatherosclerotic Effects of ACE Inhibitors  Academic Article
• Antihypertensive Drug Prescribing and Persistence Among New Elderly Users: Implications for Persistence Improvement Interventions  Academic Article
• Antihypertensive effects of perindopril treatment in adult spontaneously hypertensive rats.  Academic Article
• Antihypertensive treatment and risk of cancer: an individual participant data meta-analysis  Academic Article
• Are Patients with Inflammatory Bowel Disease at Increased Risk of Coronary Artery Disease?  Academic Article
• Aspirin and Extended-Release Dipyridamole versus Clopidogrel for Recurrent Stroke  Academic Article
• Aspirin-Resistant Thromboxane Biosynthesis and the Risk of Myocardial Infarction, Stroke, or Cardiovascular Death in Patients at High Risk for Cardiovascular Events  Academic Article
• Association between angiotensin converting enzyme inhibitor or angiotensin receptor blocker use prior to major elective surgery and the risk of acute dialysis  Academic Article
• Association of Acute Increases in Plasma Creatinine after Renin-Angiotensin Blockade with Subsequent Outcomes  Academic Article
• Association of egg intake with blood lipids, cardiovascular disease, and mortality in 177,000 people in 50 countries  Academic Article
• Atrial Fibrillation and Heart Failure in Cardiology Practice: Reciprocal Impact and Combined Management From the Perspective of Atrial Fibrillation  Academic Article
• Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data.  Academic Article
• Baseline Quality of Life as a Predictor of Mortality and Hospitalization in 5,025 Patients With Congestive Heart Failure  Academic Article
• Blockade of the renin–angiotensin–aldosterone system (RAAS) for primary prevention of non-valvular atrial fibrillation: A systematic review and meta analysis of randomized controlled trials  Academic Article
• Blocking the renin–angiotensin system: dual- versus mono-therapy  Academic Article
• Blood HER2 and Uromodulin as Causal Mediators of CKD  Academic Article
• Blood Pressure Targets Recommended by Guidelines and Incidence of Cardiovascular and Renal Events in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial (ONTARGET)  Academic Article
• Blood pressure and cardiovascular risk in the HOPE study  Academic Article
• Blood pressure control rates with an antihypertensive regimen including trandolapril in a canadian usual-care setting  Academic Article
• Blood pressure lowering and risk of new-onset type 2 diabetes: an individual participant data meta-analysis  Academic Article
• Blood pressure-dependent and independent effects of agents that inhibit the renin–angiotensin system  Academic Article
• Blood-pressure reduction and cardiovascular risk in HOPE study  Academic Article
• Canadian Cardiovascular Society Guidelines for the Diagnosis and Management of Stable Ischemic Heart Disease  Academic Article
• Canadian Cardiovascular Society Quality Indicators for Heart Failure  Academic Article
• Candesartan cilexetil is not associated with cough in hypertensive patients with enalapril-induced cough  Academic Article
• Candesartan in heart failure—assessment of reduction in mortality and morbidity (CHARM): Rationale and design  Academic Article
• Cardiovascular Risk in Patients with Early Renal Insufficiency  Academic Article
• Cardiovascular and Renal Outcomes With Telmisartan, Ramipril, or Both in People at High Renal Risk  Academic Article
• Cardiovascular and metabolic benefits of ACE inhibition: moving beyond blood pressure reduction.  Academic Article
• Cardiovascular outcomes and achieved blood pressure in patients with and without diabetes at high cardiovascular risk  Academic Article
• Cardiovascular outcomes in patients at high cardiovascular risk with previous myocardial infarction or stroke  Academic Article
• Clinical decision making and the expected value of information  Academic Article
• Clinical effects of early angiotensin-converting enzyme inhibitor treatment for acute myocardial infarction are similar in the presence and absence of aspirin  Academic Article
• Clinical experience in protecting the failing heart.  Academic Article
• Clinical features and contemporary management of patients with low and preserved ejection fraction heart failure: baseline characteristics of patients in the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) programme  Academic Article
• Clinical trials, the renin angiotensin system and atrial fibrillation  Academic Article
• Combination neurohormonal blockade with ACE inhibitors, angiotensin II antagonists and beta-blockers in patients with congestive heart failure: design of the Randomized Evaluation of Strategies for Left Ventricular Dysfunction (RESOLVD) Pilot Study.  Academic Article
• Community management of heart failure.  Academic Article
• Comparative Effectiveness of Renin-Angiotensin System Inhibitors and Calcium Channel Blockers in Individuals With Advanced CKD: A Nationwide Observational Cohort Study  Conference Paper
• Comparative Effects of Losartan and Enalapril on Exercise Capacity and Clinical Status in Patients With Heart Failure fn1fn1This study was supported by a grant from Merck Research Laboratories, West Point, Pennsylvania.  Academic Article
• Comparative Effects of Ramipril on Ambulatory and Office Blood Pressures  Academic Article
• Comparative Impact of Multiple Biomarkers and N-Terminal Pro-Brain Natriuretic Peptide in the Context of Conventional Risk Factors for the Prediction of Recurrent Cardiovascular Events in the Heart Outcomes Prevention Evaluation (HOPE) Study  Academic Article
• Comparative impact of enalapril, candesartan or metoprolol alone or in combination on ventricular remodelling in patients with congestive heart failure  Academic Article
• Comparison of Candesartan, Enalapril, and Their Combination in Congestive Heart Failure  Academic Article
• Comparison of the effects of omapatrilat and lisinopril on circulating neurohormones and cytokines in patients with chronic heart failure  Academic Article
• Comparison of the effects of standard vs low-dose prolonged-release tacrolimus with or without ACEi/ARB on the histology and function of renal allografts  Academic Article
• Contemporary Trends in Evidence-based Treatment for Acute Myocardial Infarction  Academic Article
• Contemporary management of patients with left ventricular systolic dysfunction. Results from the Study of Patients Intolerant of Converting Enzyme Inhibitors (SPICE) Registry  Academic Article
• Contemporary medical management of left ventricular dysfunction and congestive heart failure.  Academic Article
• Continuous Flow Immobilized Enzyme Reactor–Tandem Mass Spectrometry for Screening of AChE Inhibitors in Complex Mixtures  Academic Article
• Control of vascular changes by renin–angiotensin–aldosterone system in salt-sensitive hypertension  Academic Article
• Cost Implications of the Use of Ramipril in High-Risk Patients Based on the Heart Outcomes Prevention Evaluation (HOPE) Study  Academic Article
• Cost-effectiveness of β-blocker therapy with metoprolol or with carvedilol for treatment of heart failure in Canada  Academic Article
• Cross-over study comparing effects of treatment with an angiotensin converting enzyme inhibitor and an angiotensin II type 1 receptor antagonist on cardiovascular changes in hypertension  Academic Article
• Decade-long trends (1986 to 1997) in the medical treatment of patients with acute myocardial infarction: A community-wide perspective  Academic Article
• Decreasing Mortality With Primary Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction: The Mayo Clinic Experience From 1991 Through 1997  Conference Paper
• Determinants of masked hypertension in hypertensive patients treated in a primary care setting  Academic Article
• Diabetes and the HOPE study: implications for macrovascular and microvascular disease.  Academic Article
• Diabetes mellitus, a predictor of morbidity and mortality in the studies of left ventricular dysfunction (SOLVD) trials and registry  Academic Article
• Diet and Kidney Disease in High-Risk Individuals With Type 2 Diabetes Mellitus  Academic Article
• Digoxin in heart failure: results of the recent digoxin investigation group trial in the context of other treatments for heart failure  Academic Article
• Discordance Between Physicians' Estimation of Patient Cardiovascular Risk and Use of Evidence-Based Medical Therapy  Academic Article
• Does Renin-Angiotensin System Blockade Protect Lupus Nephritis Patients From Atherosclerotic Cardiovascular Events? A Case-Control Study  Academic Article
• Does spironolactone reduce the risk of urinary tract cancers in hypertensive patients?  Academic Article
• Drug Therapies in the Secondary Prevention of Cardiovascular Diseases:Successes, Shortcomings and Future Directions  Academic Article
• Dual Renin-Angiotensin System Blockade in Heart Failure  Academic Article
• Dual inhibition of the renin–angiotensin system in high-risk diabetes and risk for stroke and other outcomes  Academic Article
• Dysglycemia and a History of Reproductive Risk Factors  Academic Article
• Early Versus Delayed Enalapril in Patients With Left Ventricular Systolic Dysfunction: Impact on Morbidity and Mortality 15 Years After the SOLVD Trial  Academic Article
• Effect of Angiotensin-Converting Enzyme Inhibitors in Left Ventricular Dysfunction  Academic Article
• Effect of Ramipril and of Rosiglitazone on Carotid Intima-Media Thickness in People With Impaired Glucose Tolerance or Impaired Fasting Glucose  Academic Article
• Effect of Ramipril in Reducing Sudden Deaths and Nonfatal Cardiac Arrests in High-Risk Individuals Without Heart Failure or Left Ventricular Dysfunction  Academic Article
• Effect of Ramipril on Cardiovascular Events in High-Risk Patients  Academic Article
• Effect of Ramipril on the Incidence of Diabetes  Academic Article
• Effect of Ramipril on the Incidence of Diabetes  Academic Article
• Effect of acute angiotensin converting enzyme inhibition on left ventricular filling in patients with congestive heart failure. Relation to right ventricular volumes.  Academic Article
• Effect of angiotensin-converting enzyme inhibition on C-reactive protein levels: The Ramipril C-Reactive pRotein Randomized evaluation (4R) trial results  Academic Article
• Effect of angiotensin-converting enzyme inhibition on functional class in patients with left ventricular systolic dysfunction-a meta-analysis  Academic Article
• Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery.  Academic Article
• Effect of candesartan on New York Heart Association functional classResults of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme  Academic Article
• Effect of comorbidities on outcomes and angiotensin converting enzyme inhibitor effects in patients with predominantly left ventricular dysfunction and heart failure  Academic Article
• Effect of enalapril on 12-year survival and life expectancy in patients with left ventricular systolic dysfunction: a follow-up study  Academic Article
• Effect of long-term ACE-inhibitor therapy in elderly vascular disease patients  Academic Article
• Effect of long-term therapy with ramipril in high-risk women  Academic Article
• Effects of ACE Inhibitors on Mortality When Started in the Early Phase of Myocardial Infarction: Evidence from the Larger Randomized Controlled Trials  Academic Article
• Effects of ACE inhibitors and angiotensin receptor blockers: protocol for a UK cohort study using routinely collected electronic health records with validation against the ONTARGET trial  Academic Article
• Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials  Academic Article
• Effects of Centrally Acting Angiotensin Converting Enzyme Inhibitors on Functional Decline in Patients with Alzheimer's Disease  Academic Article
• Effects of Ramipril and Rosiglitazone on Cardiovascular and Renal Outcomes in People With Impaired Glucose Tolerance or Impaired Fasting Glucose  Academic Article
• Effects of Ramipril and Vitamin E on Atherosclerosis  Academic Article
• Effects of Ramipril on Coronary Events in High-Risk Persons  Academic Article
• Effects of Telmisartan on Glucose Levels in People at High Risk for Cardiovascular Disease but Free From Diabetes  Academic Article
• Effects of Telmisartan, Ramipril, and Their Combination on Left Ventricular Hypertrophy in Individuals at High Vascular Risk in the Ongoing Telmisartan Alone and in Combination With Ramipril Global End Point Trial and the Telmisartan Randomized Assessment Study in ACE Intolerant Subjects With Cardiovascular Disease  Academic Article
• Effects of a polypill (Polycap) on risk factors in middle-aged individuals without cardiovascular disease (TIPS): a phase II, double-blind, randomised trial  Academic Article
• Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients  Academic Article
• Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial  Academic Article
• Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial  Academic Article
• Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme  Academic Article
• Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials  Academic Article
• Effects of enalapril, candesartan or both on neurohumoral activation and LV volumes and function in patients with heart failure not treated with a beta-blocker  Academic Article
• Effects of isometric handgrip training among people medicated for hypertension: a multilevel analysis  Academic Article
• Effects of long-term treatment with angiotensin-converting-enzyme inhibitors in the presence or absence of aspirin: a systematic review  Academic Article
• Effects of myocardial fibrosis and ventricular dyssynchrony on response to therapy in new-presentation idiopathic dilated cardiomyopathy: insights from cardiovascular magnetic resonance and echocardiography  Academic Article
• Effects of nonpersistence with medication on outcomes in high-risk patients with cardiovascular disease  Academic Article
• Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy  Academic Article
• Effects of ramipril on left ventricular mass and function in cardiovascular patients with controlled blood pressure and with preserved left ventricular ejection fraction  Academic Article
• Effects of telmisartan, irbesartan, valsartan, candesartan, and losartan on cancers in 15 trials enrolling 138 769 individuals  Academic Article
• Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dilatation in patients with asymptomatic systolic dysfunction. SOLVD (Studies of Left Ventricular Dysfunction) Investigators.  Academic Article
• Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure. SOLVD Investigators.  Academic Article
• Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial  Academic Article
• Effects of withdrawing vs continuing renin-angiotensin blockers on incidence of acute kidney injury in patients with renal insufficiency undergoing cardiac catheterization: Results from the Angiotensin Converting Enzyme Inhibitor/Angiotensin Receptor Blocker and Contrast Induced Nephropathy in Patients Receiving Cardiac Catheterization (CAPTAIN) trial  Academic Article
• Efficacy and tolerability of adding an angiotensin receptor blocker in patients with heart failure already receiving an angiotensin-converting inhibitor plus aldosterone antagonist, with or without a beta blocker. Findings from the Candesartan in Heart fa  Academic Article
• Emerging approaches in preventing cardiovascular disease  Academic Article
• Emerging approaches in the prevention of atherosclerotic cardiovascular diseases.  Academic Article
• Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection.  Academic Article
• Enalapril prevents clinical proteinuria in diabetic patients with low ejection fraction.  Academic Article
• Endothelium-dependent relaxation factor released by perivascular adipose tissue  Academic Article
• Epidemiology of Decompensated Heart Failure in a Single Community in the Northeastern United States  Academic Article
• Erectile Dysfunction Predicts Cardiovascular Events in High-Risk Patients Receiving Telmisartan, Ramipril, or Both  Academic Article
• Evidence based cardiology: Prevention of congestive heart failure and management of asymptomatic left ventricular dysfunction  Academic Article
• Exploring design-related bias in clinical studies on receptor genetic polymorphism of hypertension  Academic Article
• Exposure to ACE inhibitors prior to the onset of scleroderma renal crisis—Results from the International Scleroderma Renal Crisis Survey  Academic Article
• Fatal neonatal renal failure due to maternal enalapril ingestion  Academic Article
• Felodipine–metoprolol combination tablet: a valuable option to initiate antihypertensive therapy?  Academic Article
• From ACE Inhibitors/ARBs to ARNIs in Coronary Artery Disease and Heart Failure (Part 2/5)  Academic Article
• From the hope to the ontarget and the transcend studies: challenges in improving prognosis  Academic Article
• Genetic variants associated with angiotensin-converting enzyme inhibitor-associated angioedema  Academic Article
• Glucose Levels Predict Hospitalization for Congestive Heart Failure in Patients at High Cardiovascular Risk  Academic Article
• Glucose intolerance and diabetes as risk factors for cognitive impairment in people at high cardiovascular risk: Results from the ONTARGET/TRANSCEND Research Programme  Academic Article
• HFSA Guidelines for Management of Patients With Heart Failure Caused by Left Ventricular Systolic Dysfunction—Pharmacological Approaches  Academic Article
• Heart failure and shock complicating acute coronary syndromes  Academic Article
• Heart failure between 1986 and 1994: Temporal trends in drug-prescribing practices, hospital readmissions, and survival at an academic medical center  Academic Article
• Heart failure.  Academic Article
• Heart failure.  Academic Article
• Heart failure.  Academic Article
• Heart failure.  Academic Article
• Heart failure.  Academic Article
• Heart failure.  Academic Article
• Heart failure.  Academic Article
• Heart failure.  Academic Article
• Heart rate is associated with increased risk of major cardiovascular events, cardiovascular and all-cause death in patients with stable chronic cardiovascular disease: an analysis of ONTARGET/TRANSCEND  Academic Article
• High-dose versus low-dose angiotensin converting enzyme inhibitors in heart failure: systematic review and meta-analysis  Academic Article
• Hyperkalemia with Mineralocorticoid Receptor Antagonist Use in People with CKD  Academic Article
• Hyperkalemia-Related Discontinuation of Renin-Angiotensin-Aldosterone System Inhibitors and Clinical Outcomes in CKD: A Population-Based Cohort Study  Academic Article
• Hypotensive transfusion reactions can occur with blood products that are leukoreduced before storage  Academic Article
• ISIS-4: A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58 050 patients with suspected acute myocardial infarction  Academic Article
• Impact of ACE2 gene polymorphism on antihypertensive efficacy of ACE inhibitors  Academic Article
• Impact of Estimated GFR Reporting on Patients, Clinicians, and Health-Care Systems: A Systematic Review  Academic Article
• Impact of Ramipril on the Circadian Periodicity of Acute Myocardial Infarction  Academic Article
• Impact of Sex on Cardiovascular Outcome in Patients at High Cardiovascular Risk  Academic Article
• Impact of an Initial Strategy of Medical Therapy Without Percutaneous Coronary Intervention in High-Risk Patients From the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) Trial  Academic Article
• Impact of cigarette smoking in high-risk patients participating in a clinical trial. A substudy from the Heart Outcomes Prevention Evaluation (HOPE) trial  Academic Article
• Impact of diabetes, angiotensin‐converting enzyme inhibitor or angiotensin II receptor blocker use, and statin use on presentation and outcomes in patients with giant cell arteritis  Conference Paper
• Impact of ramipril in patients with evidence of clinical or subclinical peripheral arterial disease  Academic Article
• Impact of ramipril on the incidence of atrial fibrillation: Results of the Heart Outcomes Prevention Evaluation study  Academic Article
• Implications of Diabetes in Patients With Acute Coronary Syndromes<subtitle>The Global Registry of Acute Coronary Events</subtitle>  Academic Article
• Improved Outcomes With Early Collaborative Care of Ambulatory Heart Failure Patients Discharged From the Emergency Department  Academic Article
• In a Subgroup of High-Risk Asians, Telmisartan Was Non-Inferior to Ramipril and Better Tolerated in the Prevention of Cardiovascular Events  Academic Article
• Increasing Use of Single and Combination Medical Therapy in Patients Hospitalized for Acute Myocardial Infarction in the 21st Century<subtitle>A Multinational Perspective</subtitle>  Academic Article
• Indications for ACE Inhibitors in the Early Treatment of Acute Myocardial Infarction  Academic Article
• Influence of Previous Heart Failure Hospitalization on Cardiovascular Events in Patients With Reduced and Preserved Ejection Fraction  Academic Article
• Inhibition of angiotensin-converting enzyme by captopril: A novel approach to reduce ischemia-reperfusion injury after lung transplantation  Academic Article
• Initial data supporting the design of the Candesartan in Heart failure — Assessment of Reduction in Mortality and morbidity (CHARM) programme  Academic Article
• Insights into the contemporary epidemiology and outpatient management of congestive heart failure  Academic Article
• Interventions supporting long term adherence and decreasing cardiovascular events after myocardial infarction (ISLAND): pragmatic randomised controlled trial  Academic Article
• Intrarenal Arterial Lesions Are Associated with Higher Blood Pressure, Reduced Renal Function and Poorer Renal Outcomes in Patients with IgA Nephropathy  Academic Article
• Irbesartan in Patients with Heart Failure and Preserved Ejection Fraction  Academic Article
• Is the jury out? Class specific differences on coronary outcomes with ACE-inhibitors and ARBs: insight from meta-analysis and The Blood Pressure Lowering Treatment Trialists' CollaborationThe opinions expressed in this article are not necessarily those of the Editors of the European Heart Journal or of the European Society of Cardiology.  Academic Article
• Is therapy of people with chronic kidney disease ONTARGET?  Academic Article
• Kidney Function and Potassium Monitoring After Initiation of Renin-Angiotensin-Aldosterone System Blockade Therapy and Outcomes in 2 North American Populations  Academic Article
• Left Ventricular Mass and Volume With Telmisartan, Ramipril, or Combination in Patients With Previous Atherosclerotic Events or With Diabetes Mellitus (from the ONgoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial [ONTARGET])  Academic Article
• Length of Initial Prescription at Hospital Discharge and Long-term Medication Adherence for Elderly Patients With Coronary Artery Disease: A Population-Level Study  Academic Article
• Level of Systolic Blood Pressure Within the Normal Range and Risk of Recurrent Stroke  Academic Article
• Long-Term Effects of Cholesterol Lowering and Angiotensin-Converting Enzyme Inhibition on Coronary Atherosclerosis  Academic Article
• Long-Term Effects of Ramipril on Cardiovascular Events and on Diabetes  Academic Article
• Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients  Academic Article
• Management of acute coronary syndromes in developing countries: acute coronary events-a multinational survey of current management strategies.  Academic Article
• Management of congestive heart failure  Academic Article
• Management of heart failure in Canadian long-term care facilities.  Academic Article
• Mechanisms for perivascular adipose tissue-mediated potentiation of vascular contraction to perivascular neuronal stimulation: The role of adipocyte-derived angiotensin II  Academic Article
• Medical Therapy for Chronic Congestive Heart Failure  Academic Article
• Meta-Analysis Comparing Neurohumoral Antagonist Use in Patients ≥75 Years Versus <75 Years Receiving Cardiac Resynchronization Therapy  Academic Article
• Meta-Analysis of Combined Therapy with Angiotensin Receptor Antagonists versus ACE Inhibitors Alone in Patients with Heart Failure  Academic Article
• Mineralocorticoid Receptor Antagonists in CKD: In Need of a Few Large Trials  Academic Article
• Missed opportunities for the secondary prevention of cardiovascular disease in Canada  Academic Article
• Modifying the natural history of atherosclerosis: the SECURE trial.  Academic Article
• Monitoring Initial Response to Angiotensin-Converting Enzyme Inhibitor–Based Regimens  Academic Article
• More than just hype.  Academic Article
• Net Health Plan Savings From Reference Pricing for Angiotensin-Converting Enzyme Inhibitors in Elderly British Columbia Residents  Academic Article
• No Increase in Adverse Events During Aliskiren Use Among Ontario Patients Receiving Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers  Academic Article
• Optimal Medical Therapy with or without PCI for Stable Coronary Disease  Academic Article
• Outcomes of Acute Coronary Syndrome in a Large Canadian Cohort: Impact of Chronic Renal Insufficiency, Cardiac Interventions, and Anemia  Conference Paper
• Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials  Academic Article
• Pathophysiologic and therapeutic importance of tissue ACE: a consensus report.  Academic Article
• Pathophysiology and management of angiotensin-converting enzyme inhibitor-associated refractory hypotension during the perioperative period.  Academic Article
• Patterns of angiotensin-converting enzyme inhibitor prescriptions, educational interventions, and outcomes among hospitalized patients with heart failure  Academic Article
• Patterns of cardioprotective medication prescription in incident hemodialysis patients  Academic Article
• Patterns of medical therapy in patients with peripheral artery disease in a tertiary care centre in Canada  Academic Article
• Perindopril treatment in the prevention of stroke in experimental animals  Academic Article
• Perindopril-Based Blood Pressure–Lowering Reduces Major Vascular Events in Patients With Atrial Fibrillation and Prior Stroke or Transient Ischemic Attack  Academic Article
• Peripheral arterial disease: prognostic significance and prevention of atherothrombotic complications  Academic Article
• Pharmacological treatment for myocardial infarction Part 2: Implications of clinical trials of other adjunctive therapies.  Academic Article
• Physicians' recommendations for patients who undergo noncardiac surgery.  Academic Article
• Pollen Count and Presentation of Angiotensin-Converting Enzyme Inhibitor–Associated Angioedema  Academic Article
• Practical recommendations for the use of ACE inhibitors, beta-blockers, aldosterone antagonists and angiotensin receptor blockers in heart failure: Putting guidelines into practice  Academic Article
• Pre-Hospital Cardiac Arrest in Acute Coronary Syndromes: Insights from the Global Registry of Acute Coronary Events and the Canadian Registry of Acute Coronary Events  Academic Article
• Preoperative angiotensin-converting enzyme inhibitors and angiotensin receptor blocker use and acute kidney injury in patients undergoing cardiac surgery  Academic Article
• Presentation, Diagnosis, and Medical Management of Heart Failure in Children: Canadian Cardiovascular Society Guidelines  Academic Article
• Preventing cardiovascular disease in primary care: Role of a national risk factor management program  Academic Article
• Prevention and management of hyperkalemia in patients treated with renin–angiotensin–aldosterone system inhibitors  Academic Article
• Prevention of Atrial Fibrillation With Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers  Academic Article
• Prevention of Heart Failure in Patients in the Heart Outcomes Prevention Evaluation (HOPE) Study  Academic Article
• Prevention of stroke and preservation of the functions of cerebral arteries by treatment with perindopril in stroke-prone spontaneously hypertensive rats  Academic Article
• Prevention of stroke with perindopril treatment in stroke-prone spontaneously hypertensive rats.  Academic Article
• Prognostic Significance of Plasma Norepinephrine in Patients With Asymptomatic Left Ventricular Dysfunction  Academic Article
• Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study  Academic Article
• Prognostic value of blood pressure in patients with high vascular risk in the Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial study  Academic Article
• Progression of renal insufficiency in type 2 diabetes with and without microalbuminuria: results of the Heart Outcomes and Prevention Evaluation (HOPE) randomized study  Academic Article
• RAS blockade with ARB and ACE inhibitors: current perspective on rationale and patient selection  Academic Article
• Ramipril and Risk of Diabetes—Reply  Academic Article
• Ramipril and the Development of Diabetes  Academic Article
• Ramipril in the treatment of vascular diseases  Academic Article
• Randomized trial of candesartan cilexetil in the treatment of patients with congestive heart failure and a history of intolerance to angiotensin-converting enzyme inhibitors  Academic Article
• Rationale and design features of a clinical trial examining the effects of cholesterol lowering and angiotensin-converting enzyme inhibition on coronary atherosclerosis: Simvastatin/Enalapril Coronary Atherosclerosis Trial (SCAT). SCAT Investigators.  Academic Article
• Rationale and design of a large study to evaluate the renal and cardiovascular effects of an ACE inhibitor and vitamin E in high-risk patients with diabetes. The MICRO-HOPE Study. Microalbuminuria, cardiovascular, and renal outcomes. Heart Outcomes Prevention Evaluation.  Academic Article
• Rationale and design of a study assessing treatment strategies of atrial fibrillation in patients with heart failure: The Atrial Fibrillation and Congestive Heart Failure (AF-CHF) trial  Academic Article
• Rationale, Design and Baseline Data of a Randomized, Double-Blind, Controlled Trial Comparing Two Antithrombotic Regimens (a Fixed-Dose Combination of Extended-Release Dipyridamole plus ASA with Clopidogrel) and Telmisartan versus Placebo in Patients with Strokes: The Prevention Regimen for Effectively Avoiding Second Strokes Trial (PRoFESS)  Academic Article
• Rationale, design, and baseline characteristics of 2 large, simple, randomized trials evaluating telmisartan, ramipril, and their combination in high-risk patients: the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial/Telmisartan Randomized Assessment Study in ACE Intolerant Subjects with Cardiovascular Disease (ONTARGET/TRANSCEND) trials  Academic Article
• Recent advances in the drug treatment of heart failure  Academic Article
• Recurrent events in meta-analysis of multiple clinical trials.  Academic Article
• Reduction of Cardiovascular Risk by Regression of Electrocardiographic Markers of Left Ventricular Hypertrophy by the Angiotensin-Converting Enzyme Inhibitor Ramipril  Academic Article
• Reduction of cardiovascular events and microvascular complications in diabetes with ACE inhibitor treatment: HOPE and MICRO-HOPE  Academic Article
• Regular review: Drug treatment in heart failure  Academic Article
• Relationship of dose of background angiotensin-converting enzyme inhibitor to the benefits of candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM)–Added trial  Academic Article
• Relative and Combined Prognostic Importance of On-Treatment Mean and Visit-to-Visit Blood Pressure Variability in ONTARGET and TRANSCEND Patients  Academic Article
• Reliability, validity, and responsiveness of the six-minute walk test in patients with heart failure  Academic Article
• Renal Failure, Chronic  Academic Article
• Renal Insufficiency as a Predictor of Cardiovascular Outcomes and the Impact of Ramipril: The HOPE Randomized Trial  Academic Article
• Renal outcomes and blood pressure patterns in diabetic and nondiabetic individuals at high cardiovascular risk  Academic Article
• Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial  Academic Article
• Renin Angiotensin Aldosterone System Inhibition in Controlling Dementia-Related Cognitive Decline  Academic Article
• Renin-angiotensin system blockade and cognitive function in patients at high risk of cardiovascular disease: analysis of data from the ONTARGET and TRANSCEND studies  Academic Article
• Report of the ISHLT Working Group on Primary Lung Graft Dysfunction Part VI: Treatment  Academic Article
• Reporting of the estimated glomerular filtration rate was associated with increased use of angiotensin-converting enzyme inhibitors and angiotensin-II receptor blockers in CKD  Academic Article
• Rhythm Control versus Rate Control for Atrial Fibrillation and Heart Failure  Academic Article
• Risk of Hospitalization for Community Acquired Pneumonia with Renin-Angiotensin Blockade in Elderly Patients: A Population-Based Study  Academic Article
• Role of Angiotensin Converting Enzyme Inhibitors in Patients with Left Ventricular Dysfunction and Congestive Heart Failure  Academic Article
• Role of Renin-Angiotensin System Blockade in Atherosclerotic Renal Artery Stenosis and Renovascular Hypertension  Academic Article
• Role of Renin-Angiotensin System Blockade in Patients With Diabetes Mellitus  Academic Article
• Role of the renin-angiotensin-aldosterone system in atrial fibrillation and cardiac remodeling.  Academic Article
• Serum potassium, cardiovascular risk, and effects of an ACE inhibitor: results of the HOPE Study  Academic Article
• Sexual function, satisfaction, and association of erectile dysfunction with cardiovascular disease and risk factors in cardiovascular high-risk patients: Substudy of the ONgoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNT Study in ACE-INtolerant Subjects with Cardiovascular Disease (ONTARGET/TRANSCEND)  Academic Article
• Should angiotensin-converting enzyme-inhibitors be used to improve outcome in patients with coronary artery disease and 'preserved' left ventricular function?  Academic Article
• Should patients with stable coronary artery disease be treated with ACE inhibitor therapy?  Academic Article
• Should treatment for heart failure with preserved ejection fraction differ from that for heart failure with reduced ejection fraction?  Academic Article
• Six-month effects of early treatment with lisinopril and transdermal glyceryl trinitrate singly and together withdrawn six weeks atter acute myocardial infarction: The GISSI-3 trial  Academic Article
• Skeletal muscle-endothelial cell cross talk through angiotensin II  Academic Article
• Stopping Renin-Angiotensin System Inhibitors in Patients with Advanced CKD and Risk of Adverse Outcomes: A Nationwide Study  Academic Article
• Stopping renin-angiotensin system blockers after acute kidney injury and risk of adverse outcomes: parallel population-based cohort studies in English and Swedish routine care  Academic Article
• Stopping renin-angiotensin system inhibitors after hyperkalemia and risk of adverse outcomes  Academic Article
• Studies of left ventricular dysfunction (SOLVD) registry: Rationale, design, methods and description of baseline characteristics  Academic Article
• Study Design and Baseline Characteristics of the Study to Evaluate Carotid Ultrasound Changes in Patients Treated with Ramipril and Vitamin E: SECURE**This study was supported by Research Grant Ul-12363 from the Medicine Research Council of Canada, Ottawa; and by Hoechst Marion Roussel, Laval, Canada, Inc.  Academic Article
• Study on propionyl-?-carnitine in chronic heart failure  Academic Article
• Summary of Randomized Trials of Angiotensin Converting Enzyme Inhibitors  Academic Article
• Surgical biology for the clinician: vascular effects of immunosuppression.  Academic Article
• Systolic Blood Pressure Variation and Mean Heart Rate Is Associated With Cognitive Dysfunction in Patients With High Cardiovascular Risk  Academic Article
• Systolic and Diastolic Blood Pressure Changes in Relation With Myocardial Infarction and Stroke in Patients With Coronary Artery Disease  Academic Article
• Telmisartan to Prevent Recurrent Stroke and Cardiovascular Events  Academic Article
• Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events  Academic Article
• Telmisartan, ramipril, or both in high-risk Chinese patients: analysis of ONTARGET China data.  Academic Article
• The 2001 Canadian Cardiovascular Society consensus guideline update for the management and prevention of heart failure.  Academic Article
• The 2002/3 Canadian Cardiovascular Society consensus guideline update for the diagnosis and management of heart failure.  Academic Article
• The 2010 Canadian Cardiovascular Society guidelines for the diagnosis and management of heart failure update: Heart failure in ethnic minority populations, heart failure and pregnancy, disease management, and quality improvement/assurance programs  Academic Article
• The HOPE (Heart Outcomes Prevention Evaluation) Study and its Consequences  Academic Article
• The HOPE (Heart Outcomes Prevention Evaluation) Study: the design of a large, simple randomized trial of an angiotensin-converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events. The HOPE study investigators.  Academic Article
• The HOPE study and diabetes  Academic Article
• The International Polycap Study-3 (TIPS-3): Design, baseline characteristics and challenges in conduct  Academic Article
• The Mini-Mental State Examination, Clinical Factors, and Motor Vehicle Crash Risk  Academic Article
• The Prognostic Significance of Bundle Branch Block in High-Risk Chronic Stable Vascular Disease Patients: A Report from the HOPE Trial  Academic Article
• The Role of Angiotensin II Receptor Blockers in the Treatment of Heart Failure Patients  Academic Article
• The Treatment of Heart Failure  Academic Article
• The cardiac MRI substudy to ongoing telmisartan alone and in combination with ramipril global endpoint trial/telmisartan randomized assessment study in ACE-intolerant subjects with cardiovascular disease: analysis protocol and baseline characteristics  Academic Article
• The clinical relevance of pharmacological blood pressure lowering mechanisms.  Academic Article
• The cost implications of the use of telmisartan or ramipril in patients at high risk for vascular events: the ONTARGET study  Academic Article
• The effect of combination treatment with aliskiren and blockers of the renin-angiotensin system on hyperkalaemia and acute kidney injury: systematic review and meta-analysis  Academic Article
• The effect of perindopril on cardiovascular morbidity and mortality in patients with diabetes in the EUROPA study: results from the PERSUADE substudy  Academic Article
• The effect of ramipril and telmisartan on serum potassium and its association with cardiovascular and renal events: Results from the ONTARGET trial  Academic Article
• The effect of renin–angiotensin–aldosterone system inhibitors on continuous and binary kidney outcomes in subgroups of patients with diabetes: a meta-analysis of randomized clinical trials  Academic Article
• The effect of treatment on survival in congestive heart failure  Academic Article
• The management of congestive heart failure  Academic Article
• The need to test the theories behind the Polypill: rationale behind the Indian Polycap Study  Academic Article
• The pharmacogenetics of carboxylesterases: CES1 and CES2 genetic variants and their clinical effect  Academic Article
• The relationship between dysglycaemia and cardiovascular and renal risk in diabetic and non-diabetic participants in the HOPE study: a prospective epidemiological analysis  Academic Article
• The relevance of subgroup-specific treatment effects: The Studies Of Left Ventricular Dysfunction (SOLVD) revisited  Academic Article
• The relevance of tissue angiotensin-converting enzyme: manifestations in mechanistic and endpoint data  Academic Article
• The therapeutic potential of angiotensin II receptor blockers in the treatment of heart failure  Academic Article
• To pay or not to pay? A decision and cost-utility analysis of angiotensin-converting-enzyme inhibitor therapy for diabetic nephropathy.  Academic Article
• Treatment practices and outcomes of patients with established peripheral arterial disease hospitalized with acute myocardial infarction in a community setting  Academic Article
• Two decades of progress in preventing vascular disease  Academic Article
• Understanding Antihypertensive Medication Use after Living Kidney Donation through Linked National Registry and Pharmacy Claims Data  Academic Article
• Use of Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers and Cardiovascular Outcomes in Chronic Dialysis Patients: A Population-Based Cohort Study  Academic Article
• Use of Combination Evidence-Based Medical Therapy Prior to Acute Myocardial Infarction (from the National Registry of Myocardial Infarction-4)  Academic Article
• Use of Disease-Modifying Therapies in Patients Hospitalized with Heart Failure: A Population-Based Perspective  Academic Article
• Use of ramipril in preventing stroke: double blind randomised trial  Academic Article
• Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey  Academic Article
• Usefulness of Temporal Changes in Neurohormones as Markers of Ventricular Remodeling and Prognosis in Patients With Left Ventricular Systolic Dysfunction and Heart Failure Receiving Either Candesartan or Enalapril or Both  Academic Article
• Using exercise endpoints in heart failure trials: design considerations  Academic Article
• Valsartan, Captopril, or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or Both  Academic Article
• Who is fooling us?  Academic Article
• Withholding versus Continuing Angiotensin-converting Enzyme Inhibitors or Angiotensin II Receptor Blockers before Noncardiac Surgery  Academic Article
• [After the HOPE Study. ACE inhibitor now for every diabetic patient?. Interview by Dr. Dirk Einecke].  Academic Article
• [Effects of benazepril, a new ACE inhibitor, in effort angina pectoris].  Academic Article